Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Shares Jump 13 Percent

NEW YORK (GenomeWeb News) – Shares of Helicos BioSciences climbed 13.1 percent in afternoon trade on the Nasdaq after the firm said that it had taken the first order for its HeliScope next-generation single molecule sequencing platform.
 
A company spokesperson declined to name the customer who placed the order.
 
Shares of Helicos were trading at $13.03 this afternoon.
 
At the JPMorgan Healthcare Conference in early January, Helicos President and COO Steve Lombardi said that interest from potential customers in pharma, academia, and genome centers outnumbered the nine instruments on the firm’s production floor.
 

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.